B. Tiangco

1.2k total citations
21 papers, 495 citations indexed

About

B. Tiangco is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, B. Tiangco has authored 21 papers receiving a total of 495 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 3 papers in Surgery. Recurrent topics in B. Tiangco's work include Lung Cancer Treatments and Mutations (4 papers), Cancer Treatment and Pharmacology (3 papers) and Sarcoma Diagnosis and Treatment (3 papers). B. Tiangco is often cited by papers focused on Lung Cancer Treatments and Mutations (4 papers), Cancer Treatment and Pharmacology (3 papers) and Sarcoma Diagnosis and Treatment (3 papers). B. Tiangco collaborates with scholars based in Philippines, United States and South Korea. B. Tiangco's co-authors include Jeanne A. Jordan, Joseph E. Kiss, William C. Koch, Arija Brize, Vicente Valero, Denise A. Yardley, Shaker R. Dakhil, Hope S. Rugo, Adam Brufsky and José Barrueco and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

B. Tiangco

18 papers receiving 484 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Tiangco Philippines 11 255 183 96 85 78 21 495
Firas Kreidieh Lebanon 11 241 0.9× 68 0.4× 29 0.3× 138 1.6× 99 1.3× 34 528
Wally Meyer United States 7 395 1.5× 86 0.5× 41 0.4× 55 0.6× 264 3.4× 8 623
Saïd Afqir Morocco 15 254 1.0× 71 0.4× 44 0.5× 130 1.5× 138 1.8× 62 549
Hoo G. Chun United States 15 440 1.7× 210 1.1× 35 0.4× 304 3.6× 59 0.8× 31 821
Lisa G. Ensign United States 12 188 0.7× 235 1.3× 58 0.6× 100 1.2× 44 0.6× 15 669
Omar Hasan Ali Switzerland 12 498 2.0× 138 0.8× 57 0.6× 125 1.5× 35 0.4× 20 704
Benedetta Conte Italy 12 331 1.3× 183 1.0× 38 0.4× 193 2.3× 171 2.2× 41 574
Pascal Chanu France 13 137 0.5× 53 0.3× 18 0.2× 68 0.8× 33 0.4× 29 403
Andrew Loh United Kingdom 6 188 0.7× 119 0.7× 44 0.5× 43 0.5× 50 0.6× 6 410
John Broggio United Kingdom 15 373 1.5× 102 0.6× 12 0.1× 68 0.8× 209 2.7× 33 672

Countries citing papers authored by B. Tiangco

Since Specialization
Citations

This map shows the geographic impact of B. Tiangco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Tiangco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Tiangco more than expected).

Fields of papers citing papers by B. Tiangco

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Tiangco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Tiangco. The network helps show where B. Tiangco may publish in the future.

Co-authorship network of co-authors of B. Tiangco

This figure shows the co-authorship network connecting the top 25 collaborators of B. Tiangco. A scholar is included among the top collaborators of B. Tiangco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Tiangco. B. Tiangco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Tiangco, B., et al.. (2024). Challenges in the maintenance of an open hospital-based cancer registry system in a low-to-middle-income country (LMIC): 2017–2022 experience. SHILAP Revista de lepidopterología. 3(1). e0000328–e0000328. 4 indexed citations
3.
Tiangco, B., et al.. (2022). A machine learning-based SNP-set analysis approach for identifying disease-associated susceptibility loci. Scientific Reports. 12(1). 15817–15817. 13 indexed citations
4.
Tiangco, B., et al.. (2021). Artificial intelligence on COVID-19 pneumonia detection using chest xray images. PLoS ONE. 16(10). e0257884–e0257884. 25 indexed citations
5.
Abad, Cybéle Lara R., et al.. (2021). Early experience with COVID-19 patients in a private tertiary hospital in the Philippines: Implications on surge capacity, healthcare systems response, and clinical care. Clinical Epidemiology and Global Health. 10. 100695–100695. 9 indexed citations
6.
Stebbing, Justin, Alexey Manikhas, Vladimir Moiseyenko, et al.. (2021). Long-term efficacy and safety of CT-P6 versus trastuzumab in patients with HER2-positive early breast cancer: final results from a randomized phase III trial. Breast Cancer Research and Treatment. 188(3). 631–640. 15 indexed citations
7.
Bonvalot, Sylvie, Piotr Rutkowski, Juliette Thariat, et al.. (2021). Long-term evaluation of the novel radioenhancer NBTXR3 plus radiotherapy in patients with locally advanced soft tissue sarcoma treated in the phase II/III Act.In.Sarc trial.. Journal of Clinical Oncology. 39(15_suppl). 11544–11544. 2 indexed citations
8.
Esteva, Francisco J., Alexey Manikhas, Vladimir Moiseyenko, et al.. (2019). Efficacy and safety of CT-P6 versus reference trastuzumab in HER2-positive early breast cancer: updated results of a randomised phase 3 trial. Cancer Chemotherapy and Pharmacology. 84(4). 839–847. 25 indexed citations
9.
Bonvalot, S., Piotr Rutkowski, Juliette Thariat, et al.. (2018). A phase II/III trial of hafnium oxide nanoparticles activated by radiotherapy in the treatment of locally advance soft tissue sarcoma of the extremity and trunk wall. Annals of Oncology. 29. viii753–viii753. 9 indexed citations
10.
Bonvalot, Sylvie, Piotr Rutkowski, Juliette Thariat, et al.. (2018). Act.in.Sarc: An International Randomized Phase III Trial Evaluating Efficacy and Safety of First-in-Class NBTXR3 Hafnium Oxide Nanoparticles Activated By Preoperative Radiotherapy in Locally Advanced Soft Tissue Sarcoma. International Journal of Radiation Oncology*Biology*Physics. 102(5). 1606–1606. 1 indexed citations
11.
12.
Kubota, Kaoru, Y. Ichinose, Giorgio V. Scagliotti, et al.. (2014). Phase III study (MONET1) of motesanib plus carboplatin/paclitaxel in patients with advanced nonsquamous nonsmall-cell lung cancer (NSCLC): Asian subgroup analysis. Annals of Oncology. 25(2). 529–536. 20 indexed citations
13.
14.
Brufsky, Adam, Vicente Valero, B. Tiangco, et al.. (2012). Second-line bevacizumab-containing therapy in patients with triple-negative breast cancer: subgroup analysis of the RIBBON-2 trial. Breast Cancer Research and Treatment. 133(3). 1067–1075. 103 indexed citations
15.
Ichinose, Yukito, Kaoru Kubota, Giorgio V. Scagliotti, et al.. (2012). Phase III study (MONET1) of motesanib plus carboplatin/paclitaxel (C/P) in patients with advanced nonsquamous non-small cell lung cancer (NSCLC): Asian subgroup analysis.. Journal of Clinical Oncology. 30(15_suppl). 7549–7549.
16.
Brufsky, Adam, Vicente Valero, B. Tiangco, et al.. (2011). Bevacizumab (BEV) plus second-line taxane (TAX) or other chemotherapy (CT) for triple-negative breast cancer (TNBC): Subgroup analysis of RIBBON-2.. Journal of Clinical Oncology. 29(27_suppl). 290–290. 2 indexed citations
17.
Brufsky, Adam, Vicente Valero, B. Tiangco, et al.. (2011). Impact of bevacizumab (BEV) on efficacy of second-line chemotherapy (CT) for triple-negative breast cancer (TNBC): Analysis of RIBBON-2.. Journal of Clinical Oncology. 29(15_suppl). 1010–1010. 20 indexed citations
18.
Tiangco, B., et al.. (2010). Nutritional status of cancer patients admitted for chemotherapy at the National Kidney and Transplant Institute.. PubMed. 51(11). 860–4. 15 indexed citations
19.
Tiangco, B., et al.. (2008). The status of blood and marrow transplantation in Philippines. Bone Marrow Transplantation. 42(S1). S118–S120. 4 indexed citations
20.
Jordan, Jeanne A., B. Tiangco, Joseph E. Kiss, & William C. Koch. (1998). Human Parvovirus B19: Prevalence of Viral DNA in Volunteer Blood Donors and Clinical Outcomes of Transfusion Recipients. Vox Sanguinis. 75(2). 97–102. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Firas Kreidieh Breakdown of academic impact, for papers by Wally Meyer Breakdown of academic impact, for papers by Saïd Afqir Breakdown of academic impact, for papers by Hoo G. Chun Breakdown of academic impact, for papers by Lisa G. Ensign Breakdown of academic impact, for papers by Omar Hasan Ali Breakdown of academic impact, for papers by Benedetta Conte Breakdown of academic impact, for papers by Pascal Chanu Breakdown of academic impact, for papers by Andrew Loh Breakdown of academic impact, for papers by John Broggio
Rankless by CCL
2026